FDA clears ‘rapid’ Terumo BCT collection system as demand for plasma-based therapies grows worldwide 22-Mar-2022 By Jane Byrne The US Food and Drug Administration (FDA) has cleared a new plasma collection system developed by Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company based in Colorado.
New approaches urged to boost collection of plasma in EU 15-Nov-2021 By Jane Byrne There is an urgent need to increase plasma donations in the EU, says the Plasma Protein Therapeutics Association (PPTA).
Trade group accuses FDA of rendering COVID-19 plasma units unusable 27-Aug-2020 By Nick Taylor FDA faces criticism over labeling that has allegedly made “hundreds, if not thousands, of in-date, ready to transfuse” COVID-19 plasma units unusable.
Takeda agrees license to strengthen plasma pipeline 27-Apr-2020 By Ben Hargreaves Takeda in global licensing agreement with ProThera to develop plasma-based therapies for inflammatory conditions.
FDA looks to accelerate plasma therapies for coronavirus 06-Apr-2020 By Ben Hargreaves US FDA looks to coordinate and speed up the development of blood-derived therapies to treat patients with COVID-19.
First US patient receives plasma therapy for coronavirus 31-Mar-2020 By Ben Hargreaves FDA grants approval for the use of donated plasma from a recovered COVID-19 patient to be infused into a critically ill patient.
Kamada raises $25M to pick up products to fill manufacturing facility 30-Jan-2020 By Nick Taylor Kamada sells shares to private equity group to support push to fill capacity at plasma production site.
Takeda plans 65% increase in plasma manufacturing capacity 26-Nov-2019 By Nick Taylor Takeda commits to 65% increase in plasma manufacturing capacity to support business acquired in takeover of Shire.
